Enterprise Software M&A Achieves Record Growth, Despite Shrink In Private Equity Investment, Says Hampleton Partners’ Report
Enterprise Software M&A Achieves Record Growth, Despite Shrink In Private Equity Investment, Says Hampleton Partners’ Report
London, UK – 8 March 2023. The latest Enterprise Software M&A report from Hampleton Partners, the international M&A and corporate finance advisory firm for technology companies, reveals how the sector maintained its high-growth trajectory in 2022 with a record-breaking 1,837 deals, up 8 per cent compared to 2021’s 1,702 deals. This was achieved despite the turbulent macro environment and a slow-down in deal activity in the second-half of 2022.
Share of private equity deals shrinks
In 2022 private equity acquisitions as a percentage of total acquisitions dropped to 36 per cent, a six-year low due to higher interest rates, a reversal of the previous three-year trend. Between 2019 and 2021 financial sponsors’ share averaged 41 per cent. The median private equity deal size, however, remained significantly higher at $200m compared to $45m paid by strategic buyers.
The volume of deals exceeding $1 billion fell, with 10 transactions versus 19 in the first half.
Miro Parizek, founder and principal partner, Hampleton Partners, said: “Inflation, supply chain strain and continued geopolitical conflict have placed pressures on both tech giants and small vendors, but the enterprise software sector maintained its record-breaking run in 2022.
“Many cash positive acquirers are deploying capital reserves to acquire smaller firms to bolster product offerings and consolidate their market share.
“Private equity firms are enacting roll-up strategies to challenge incumbent firms and build market-leading companies on a global scale. With vast reserves of dry powder, private equity has reduced the quantity of platform acquisitions, but has increased cheque sizes to mitigate portfolio risk.”
Top Enterprise Software acquirers – past 30 months
The second half of 2022 saw Norway-based Visma move up to top acquirer with 25 deals closed over the past 30 months, seven of which were inked in 2H2022.
Visma – 25 acquisitions including P8 Software, Flex Applications and Datapas
Volaris – 21 acquisitions including Evans CaseLoad, ArtBinder and Equiplano Sistemas
Valsoft – 20 acquisitions including Monaco, T-Innova and Ingeniera Aplicada and Apero Solutions
Thoma Bravo – 20 acquisitions including Coupa Software, SMA Technologies and Anaplan
Largest disclosed Enterprise Software deals of 2H2022
$20.0 bn – Adobe acquired Figma Inc.
$8.2 bn - Vista Equity Partners acquired Avalara at 10.6x revenue
$7.4 bn - CVS Health Corporation acquired Signify Health at 9.3x revenue
Hampleton’s Enterprise Software M&A Report analyses transactions, trends and activity across the Enterprise Applications; Business Intelligence & Customer Analytics; Information Management; Vertical Applications; Infrastructure Management and Design, Testing & Simulation segments.
Download the full Hampleton Partners’ Enterprise Software M&A Market Report 1H2023: https://www.hampletonpartners.com/reports/enterprise-software-report/.
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.